Pancreatic Cancer Research

ResearcherUniversity of California, San FranciscoNo recent work listed

Pelin Cinar

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-1247-353X; OpenAlex author ID A5009409407. Sources: OpenAlex.

Their work

Papers
9 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
26
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: 1 paper · 2015: none · 2016: none · 2017: 1 paper · 2018: 1 paper · 2019: 1 paper · 2020: 1 paper · 2021: 1 paper · 2022: 2 papers

Papers 9

  1. The Additional Diagnostic Benefit of Pancreatic Cancer Molecular Profiling After Germline Testing. Co-author DOI 10.1097/mpa.0000000000002021↗
  2. Multidisciplinary Management of Pancreatic Cancer. Co-author DOI 10.6004/jadpro.2022.13.3.26↗
  3. Implementation of an Embedded In-Clinic Genetic Testing Station to Optimize Germline Testing for Patients with Pancreatic Adenocarcinoma. Co-author DOI 10.1002/onco.13968↗
  4. Metastatic Pancreatic Cancer: ASCO Guideline Update. Co-author DOI 10.1200/jco.20.01364↗
  5. CA 19-9 Response: A Surrogate to Predict Survival in Patients With Metastatic Pancreatic Adenocarcinoma. First author DOI 10.1097/coc.0000000000000620↗
  6. Early Response Assessment in Pancreatic Ductal Adenocarcinoma Through Integrated PET/MRI. Co-author DOI 10.2214/ajr.18.19602↗
  7. Best practices for the treatment of metastatic pancreatic adenocarcinoma: the therapeutic landscape in 2017. Co-author DOI 10.21037/cco.2017.06.13↗
  8. Evolving treatment options for locally advanced unresectable pancreatic ductal adenocarcinoma. Co-author DOI 10.6004/jnccn.2014.0017↗
  9. Monoclonal antibodies and other targeted therapies for pancreatic cancer. Co-author DOI 10.1097/ppo.0b013e3182758985↗

Closest collaborators

The 25 strongest of 26 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Andrew H. Ko · 6 shared papers, 2014–2022 · strength 0.74
  2. Margaret A. Tempero · 5 shared papers, 2012–2022 · strength 0.57
  3. Patricia Zendejas · 1 shared paper, 2022 · strength 0.33
  4. Julia C. Carnevale · 2 shared papers, 2021–2022 · strength 0.30
  5. Evan Justin Walker · 2 shared papers, 2021–2022 · strength 0.30
  6. Eric Andrew Collisson · 2 shared papers, 2018–2021 · strength 0.20
  7. Eric Andrew Collisson · 1 shared paper, 2022 · strength 0.17
  8. Jimmy J. Hwang · 1 shared paper, 2019 · strength 0.12
  9. Celso L. Diaz · 1 shared paper, 2019 · strength 0.12
  10. Mallika Dhawan · 1 shared paper, 2021 · strength 0.12
  11. Davendra P. S. Sohal · 1 shared paper, 2020 · strength 0.09
  12. Thierry Conroy · 1 shared paper, 2020 · strength 0.09
  13. Eileen Mary O'Reilly · 1 shared paper, 2020 · strength 0.09
  14. Mehmet Sitki Copur · 1 shared paper, 2020 · strength 0.09
  15. Smitha Krishnamurthi · 1 shared paper, 2020 · strength 0.09
  16. Neeha Zaidi · 1 shared paper, 2020 · strength 0.09
  17. Tyler Paul Johnson · 1 shared paper, 2020 · strength 0.09
  18. Hope Elizabeth Uronis · 1 shared paper, 2020 · strength 0.09
  19. Christopher H. Crane · 1 shared paper, 2020 · strength 0.09
  20. Vaibhav Sahai · 1 shared paper, 2020 · strength 0.09
  21. Ignacio Garrido‐Laguna · 1 shared paper, 2020 · strength 0.09
  22. Shubham Pant · 1 shared paper, 2020 · strength 0.09
  23. Philip A. Philip · 1 shared paper, 2020 · strength 0.09
  24. Daniel A. Laheru · 1 shared paper, 2020 · strength 0.09
  25. Zhen J. Wang · 1 shared paper, 2018 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.